These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26555326)

  • 1. Weight Loss, The Obesity Paradox in Rheumatoid Arthritis: Is It a Paradox? Comment on the Article by Baker et al.
    Gremese E; Tolusso B; Ferraccioli G
    Arthritis Rheumatol; 2016 Feb; 68(2):553. PubMed ID: 26555326
    [No Abstract]   [Full Text] [Related]  

  • 2. Rheumatoid arthritis: Debunking the obesity-mortality paradox in RA.
    Sattar N; McInnes IB
    Nat Rev Rheumatol; 2015 Aug; 11(8):445-6. PubMed ID: 26150124
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply.
    Baker JF; Ibrahim S; Billig E; Michaud K; Caplan L; Cannon GW; Stokes A; Majithia V; Mikuls TR
    Arthritis Rheumatol; 2016 Feb; 68(2):553-4. PubMed ID: 26555220
    [No Abstract]   [Full Text] [Related]  

  • 4. Weight Loss, the Obesity Paradox, and the Risk of Death in Rheumatoid Arthritis.
    Baker JF; Billig E; Michaud K; Ibrahim S; Caplan L; Cannon GW; Stokes A; Majithia V; Mikuls TR
    Arthritis Rheumatol; 2015 Jul; 67(7):1711-7. PubMed ID: 25940140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and early life weight and associations with mortality in rheumatoid arthritis.
    Baker JF; Stokes A; Mikuls TR; George M; England BR; Sayles H; Michaud K
    Clin Exp Rheumatol; 2019; 37(5):768-773. PubMed ID: 30719967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Rheumatoid Arthritis Cause an Obesity Paradox? Comment on the Article by Sparks et al.
    Baker JF; Kerr G; Mikuls TR
    Arthritis Rheumatol; 2018 Apr; 70(4):627. PubMed ID: 29342500
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in fat free mass in overweight patients with rheumatoid arthritis on a weight reducing regimen. A comparison of eight different body composition methods.
    Heitmann BL; Kondrup J; Engelhart M; Kristensen JH; Pødenphant J; Høie H; Andersen V
    Int J Obes Relat Metab Disord; 1994 Dec; 18(12):812-9. PubMed ID: 7894520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the "lipid paradox" in rheumatoid arthritis really a paradox? Comment on the article by Bartels et al.
    Strandberg TE; Kovanen PT; Eklund KK
    Arthritis Rheum; 2011 Nov; 63(11):3644-5; author's reply 3645-6. PubMed ID: 21834060
    [No Abstract]   [Full Text] [Related]  

  • 9. Obesity, sarcopenia, and arthritis and the theory of relativity: comment on the article by Baker et al.
    Moura CA; Santiago M; Rosa F; Moura CG
    Arthritis Care Res (Hoboken); 2023 Jun; 75(6):1383-1384. PubMed ID: 36226628
    [No Abstract]   [Full Text] [Related]  

  • 10. Reponse to methotrexate and reduced mortality in patients with rheumatoid arthritis: comment on the article by Krause et al.
    Alarcón GS
    Arthritis Rheum; 2000 Aug; 43(8):1902-3. PubMed ID: 10943886
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence for interaction between disease severity and comorbidity in rheumatoid arthritis? comment on the article by Navarro-Cano et al.
    Boers M
    Arthritis Rheum; 2004 May; 50(5):1695; author reply 1696-7. PubMed ID: 15146445
    [No Abstract]   [Full Text] [Related]  

  • 12. Mortality rates among patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: comment on the article by Simard et al.
    Moulis G; Sommet A; Lapeyre-Mestre M
    Arthritis Rheum; 2013 Jun; 65(6):1670-1. PubMed ID: 23508973
    [No Abstract]   [Full Text] [Related]  

  • 13. Signs of systemic disease are strong determinants of mortality in rheumatoid arthritis: comment on the article by Navarro-Cano et al.
    Turesson C; Matteson EL
    Arthritis Rheum; 2004 May; 50(5):1695-6; author reply 1696-7. PubMed ID: 15146444
    [No Abstract]   [Full Text] [Related]  

  • 14. Neoplasms as the leading cause of death among patients with rheumatoid arthritis receiving tumor necrosis factor inhibitors: comment on the article by Simard et al.
    Yazici H; Tascilar K; Yazici Y
    Arthritis Rheum; 2013 Jun; 65(6):1670. PubMed ID: 23508926
    [No Abstract]   [Full Text] [Related]  

  • 15. Intolerance to caffeine may increase susceptibility to rheumatoid arthritis: comment on the article by Mikuls et al.
    McGrath H
    Arthritis Rheum; 2002 Nov; 46(11):3104; author reply 3104-5. PubMed ID: 12428261
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of weight loss on endothelial functions in obesity: response to Sciacqua et al.
    Esposito K; Di Palo C; Marfella R; Giugliano D
    Diabetes Care; 2003 Oct; 26(10):2968-9. PubMed ID: 14514624
    [No Abstract]   [Full Text] [Related]  

  • 17. Should the definition of clinical remission of rheumatoid arthritis be revised? Comment on the article by Molenaar et al.
    Rothschild B
    Arthritis Rheum; 2004 Oct; 50(10):3397; author reply 3397-8. PubMed ID: 15476237
    [No Abstract]   [Full Text] [Related]  

  • 18. Rheumatoid arthritis, fecundity, and coital rates: comment on the article by Nelson et al.
    James W
    Arthritis Rheum; 1993 Nov; 36(11):1637. PubMed ID: 8240445
    [No Abstract]   [Full Text] [Related]  

  • 19. An alternative, autonomic rationale for decreased risk of myocardial infarction in patients with rheumatoid arthritis responsive to anti-tumor necrosis factor therapy: comment on the article by Dixon et al.
    Holman AJ
    Arthritis Rheum; 2008 Jun; 58(6):1886; author reply 1886. PubMed ID: 18512805
    [No Abstract]   [Full Text] [Related]  

  • 20. Severity of rheumatoid arthritis in Greek versus English patients: comment on the article by Drosos et al.
    Christodoulou D
    Arthritis Rheum; 1995 Sep; 38(9):1344-5. PubMed ID: 7575735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.